Abstract:The enzyme FabH plays a critical role in the initial step of fatty acid biosynthesis, which is vital for the survival of bacteria. As a result, FabH has emerged as an appealing target for the development of novel antibacterial agents. In this study, employing the chemical proteomics method, we validated the previously identified skeleton amide derivatives bearing dioxygenated rings, potentially formed through metabolic processes. Building upon the proteomics findings, we then synthesized and evaluated 32 compounds containing N -heterocyclic amides for their antimicrobial activity for future optimizing the deoxygenated amides. Several compounds demonstrated potent antimicrobial properties with low toxicity, particularly compound 25 , which exhibited remarkable potential as an agent with an MIC range of 1.25–3.13 μg/mL against the tested bacterial strains and an IC 50 of 2.0 μM against E. coli -derived FabH. Furthermore, we evaluated nine analogues with relatively low MIC values through cytotoxicity and hemolytic activity assessments, Lipinski's rule-of-five criteria, and in silico ADMET predictions to ascertain their druggability potential. Notably, a detailed docking simulation was performed to investigate the binding interactions of compound 25 within the binding pocket of E. coli FabH, which encouragingly revealed strong binding interactions. Based on our findings, compound 25 emerges as the optimal candidate for in vivo therapy aimed at treating infected skin defects. Remarkably, the application of compound 25 demonstrated a significant reduction in the duration of wound infection and notably accelerated the healing process of infected wounds, achieving an impressive 94 % healing rate by day 10.

Toward More Selective Antibiotic Inhibitors: A Structural View of the Complexed Binding Pocket of E. coli Peptide Deformylase

New peptide deformylase inhibitors design, synthesis and pharmacokinetic assessment

Expression, Purification, and Activity Assay of Peptide Deformylase from Escherichia Coli and Staphylococcus Aureus.

Recent progress in peptide deformylase and its inhibitors

Identification of Novel Potent Bicyclic Peptide Deformylase Inhibitors.

Peptide deformylase inhibitors of Mycobacterium tuberculosis: Synthesis, structural investigations, and biological results

Characterization of Peptide Deformylase Homologues from Staphylococcus Epidermidis

Unique structural characteristics of peptide deformylase from pathogenic bacterium Leptospira interrogans.

Investigation of Zinc-Containing Peptide Deformylase from Leptospira Interrogans by X-Ray Absorption Near-Edge Spectroscopy

Novel Conformational States of Peptide Deformylase from Pathogenic Bacterium Leptospira Interrogans

The Evolution of the Inhibitors of Peptide Deformylase As a New Antibacterial Target

H-Phosphonate Derivatives As Novel Peptide Deformylase Inhibitors

Co-crystallization of Leptospira interrogans peptide deformylase with a potent inhibitor and molecular-replacement schemes with eight subunits in an asymmetric unit.

3D-QSAR and Molecular Docking Studies of Hydroxamic Acids As Peptide Deformylase Inhibitors

Peptide Deformylase is a Potential Target for Anti-Helicobacter Pylori Drugs: Reverse Docking, Enzymatic Assay, and X-ray Crystallography Validation.

Synthesis, Molecular Modeling and Biological Evaluation of PSB As Targeted Antibiotics.

Theoretical Study of the Catalytic Mechanism and Metal-Ion Dependence of Peptide Deformylase

Design, Synthesis and Molecular Docking of Amide and Urea Derivatives As Escherichia Coli PDHc-E1 Inhibitors.

DESIGN AND SYNTHESIS OF NOVEL 1,2,3–TRIAZOLE SCAFFOLDS: BIOLOGICAL ACTIVITY AND MOLECULAR DOCKING STUDIES

Directed Evolution Using Stabilized Bacterial Peptide Display

Target identification, and optimization of dioxygenated amide derivatives as potent antibacterial agents with FabH inhibitory activity